Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients.
- DOI
- 10.1038/s41537-024-00473-1
- Published
- 2024 May 17
- Container
- Schizophrenia (Heidelberg, Germany)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41537-024-00473-1,
title = {Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients.},
author = {Lin C and Zhang S and Yang P and Zhang B and Guo W and Wu R and Liu Y and Wang J and Wu H and Cai H},
year = {2024},
journal = {Schizophrenia (Heidelberg, Germany)},
doi = {10.1038/s41537-024-00473-1},
url = {https://doi.org/10.1038/s41537-024-00473-1}
}RIS
TY - JOUR TI - Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients. AU - Lin C AU - Zhang S AU - Yang P AU - Zhang B AU - Guo W AU - Wu R AU - Liu Y AU - Wang J AU - Wu H AU - Cai H PY - 2024 JO - Schizophrenia (Heidelberg, Germany) DO - 10.1038/s41537-024-00473-1 UR - https://doi.org/10.1038/s41537-024-00473-1 ER -
APA
C, L., S, Z., P, Y., B, Z., W, G., R, W., Y, L., J, W., H, W., & H, C. (2024). Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients.. Schizophrenia (Heidelberg, Germany). https://doi.org/10.1038/s41537-024-00473-1
Source records
- pubmed · retrieved 2026-09-26T07:54:54.221Z